302 related articles for article (PubMed ID: 26774355)
21. Occurrence of BAP1 germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: A pilot study.
Cabaret O; Perron E; Bressac-de Paillerets B; Soufir N; de la Fouchardière A
Genes Chromosomes Cancer; 2017 Sep; 56(9):691-694. PubMed ID: 28560743
[TBL] [Abstract][Full Text] [Related]
22. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
[TBL] [Abstract][Full Text] [Related]
23. BAP1 germline mutation in two first grade family members with uveal melanoma.
Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
[TBL] [Abstract][Full Text] [Related]
24. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome.
Busam KJ; Wanna M; Wiesner T
JAMA Dermatol; 2013 Mar; 149(3):335-9. PubMed ID: 23552620
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
[TBL] [Abstract][Full Text] [Related]
26. Ambiguous melanocytic tumors with loss of 3p21.
Yeh I; Mully TW; Wiesner T; Vemula SS; Mirza SA; Sparatta AJ; McCalmont TH; Bastian BC; LeBoit PE
Am J Surg Pathol; 2014 Aug; 38(8):1088-95. PubMed ID: 24705312
[TBL] [Abstract][Full Text] [Related]
27. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM
BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282
[TBL] [Abstract][Full Text] [Related]
28. GROWTH OF PRESUMED CHOROIDAL NEVUS INTO MELANOMA OVER 4 YEARS IN BAP1 TUMOR PREDISPOSITION SYNDROME.
Masoomian B; Shields CL; Mashayekhi A; Ganguly A; Shields JA
Retin Cases Brief Rep; 2021 Mar; 15(2):93-96. PubMed ID: 29994997
[TBL] [Abstract][Full Text] [Related]
29. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
30. RAF1 Gene Fusions as a Possible Driver Mechanism in Rare BAP1-Inactivated Melanocytic Tumors: A Report of 2 Cases.
Donati M; Martinek P; Kastnerova L; Persichetti P; Michal M; Kazakov DV
Am J Dermatopathol; 2020 Dec; 42(12):961-966. PubMed ID: 32769548
[TBL] [Abstract][Full Text] [Related]
31. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
Piris A; Mihm MC; Hoang MP
Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
[TBL] [Abstract][Full Text] [Related]
32. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Njauw CN; Kim I; Piris A; Gabree M; Taylor M; Lane AM; DeAngelis MM; Gragoudas E; Duncan LM; Tsao H
PLoS One; 2012; 7(4):e35295. PubMed ID: 22545102
[TBL] [Abstract][Full Text] [Related]
33. Clinical, dermoscopic, histological and molecular analysis of BAP1-inactivated melanocytic naevus/tumour in two familial cases of BAP1 syndrome.
Moawad S; Reigneau M; de la Fouchardière A; Soufir N; Schmutz JL; Granel-Brocard F; Phan A; Bursztejn AC
Br J Dermatol; 2018 Oct; 179(4):973-975. PubMed ID: 29754391
[No Abstract] [Full Text] [Related]
34. BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature.
Donati M; Šteiner P; Kazakov DV
Am J Dermatopathol; 2023 Feb; 45(2):117-122. PubMed ID: 36669076
[TBL] [Abstract][Full Text] [Related]
35. Novel insights into the BAP1-inactivated melanocytic tumor.
Donati M; Martinek P; Steiner P; Grossmann P; Vanecek T; Kastnerova L; Kolm I; Baneckova M; Donati P; Kletskaya I; Kalmykova A; Feit J; Blasch P; Szilagyi D; Baldi A; Persichetti P; Crescenzi A; Michal M; Kazakov DV
Mod Pathol; 2022 May; 35(5):664-675. PubMed ID: 34857909
[TBL] [Abstract][Full Text] [Related]
36. Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.
Aung PP; Nagarajan P; Tetzlaff MT; Curry JL; Tang G; Abdullaev Z; Pack SD; Ivan D; Prieto VG; Torres-Cabala CA
Am J Dermatopathol; 2019 Mar; 41(3):167-179. PubMed ID: 30801340
[TBL] [Abstract][Full Text] [Related]
37. Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
Betti M; Casalone E; Ferrante D; Romanelli A; Grosso F; Guarrera S; Righi L; Vatrano S; Pelosi G; Libener R; Mirabelli D; Boldorini R; Casadio C; Papotti M; Matullo G; Magnani C; Dianzani I
Genes Chromosomes Cancer; 2015 Jan; 54(1):51-62. PubMed ID: 25231345
[TBL] [Abstract][Full Text] [Related]
38. Germline BAP1 mutations predispose also to multiple basal cell carcinomas.
de la Fouchardière A; Cabaret O; Savin L; Combemale P; Schvartz H; Penet C; Bonadona V; Soufir N; Bressac-de Paillerets B
Clin Genet; 2015 Sep; 88(3):273-7. PubMed ID: 25080371
[TBL] [Abstract][Full Text] [Related]
39. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.
Cebulla CM; Binkley EM; Pilarski R; Massengill JB; Rai K; Liebner DA; Marino MJ; Singh AD; Abdel-Rahman MH
Ophthalmic Genet; 2015 Jun; 36(2):126-31. PubMed ID: 25687217
[TBL] [Abstract][Full Text] [Related]
40. Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction.
Cheung M; Kadariya Y; Talarchek J; Pei J; Ohar JA; Kayaleh OR; Testa JR
Cancer Lett; 2015 Dec; 369(2):261-5. PubMed ID: 26409435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
